Cargando…

Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma

BACKGROUND: Immunohistochemistry using antibody cocktails against basal cell specific and cancer-associated markers is important in the diagnosis of prostate carcinoma in needle biopsies. We compared the usefulness for detecting prostate carcinoma of a three-marker cocktail of antibodies to α-methyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabir, Parag Deepak, Ottosen, Peter, Høyer, Søren, Hamilton-Dutoit, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434074/ https://www.ncbi.nlm.nih.gov/pubmed/22800084 http://dx.doi.org/10.1186/1746-1596-7-81

Ejemplares similares

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm
por: Rathod, Santosh G., et al.
Publicado: (2019)

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016)

Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium
por: Nili, Fatemeh, et al.
Publicado: (2023)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions
por: Hasan, Ikram A., et al.
Publicado: (2020)

Differentiation of renal cell tumors with morphological cocktails using a minimal panel of immunohistochemical markers
por: Rao, B. Vishal, et al.
Publicado: (2020)

Pseudohyperplastic variant of adenocarcinoma as a component of α-methyl–CoA-racemase (AMACR negative) carcinosarcoma of the prostate
por: Dudani, Sharmila, et al.
Publicado: (2015)

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2018)

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020)

Selection of aptamers for AMACR detection from DNA libraries with different primers
por: Yang, Deng-Kai, et al.
Publicado: (2018)

Evaluation of Combined Quantification of PCA3 and AMACR Gene Expression for Molecular Diagnosis of Prostate Cancer in Moroccan Patients by RT-qPCR
por: Maane, Imane Abdellaoui, et al.
Publicado: (2016)

A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2019)

A study on the AMACR catalysed elimination reaction and its application to inhibitor testing
por: Yevglevskis, Maksims, et al.
Publicado: (2016)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Correction: A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
por: Rastogi, Anshu, et al.
Publicado: (2016)

p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12
por: Brustmann, Hermann
Publicado: (2015)

AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma
por: He, Hong-Lin, et al.
Publicado: (2018)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
por: Alston, Erin L. J., et al.
Publicado: (2019)

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
por: Ather, M Hammad, et al.
Publicado: (2008)

Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor
por: Lin, Po-Yuan, et al.
Publicado: (2012)

The Role of AMACR, CD10, TMPRSS2-ERG, and p27 Protein Expression Among Different Gleason Grades of Prostatic Adenocarcinoma on Needle Biopsy
por: Gülhan, Özdemir, et al.
Publicado: (2020)

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

A cocktail of antibodies for COVID-19 therapy
por: Matthews, Dean B.
Publicado: (2020)

A counterintuitive antibody cocktail disrupts coxsackievirus
por: Zost, Seth J., et al.
Publicado: (2022)

Immunohistochemical characteristics of basal-like breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2017)

The cosmic cocktail: three parts dark matter
por: Freese, Katherine
Publicado: (2014)

Deletion Hotspots in AMACR Promoter CpG Island Are cis-Regulatory Elements Controlling the Gene Expression in the Colon
por: Zhang, Xiang, et al.
Publicado: (2009)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps
por: Dayi, Nimet, et al.
Publicado: (2013)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

Influence of Cocktails of Labeled Monoclonal Antibodies on the Localization of Antibodies in Human Tumor Xenografts
por: Watanabe, Yuji, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_gc55tgga5p0i12mc0u956dlmdn